|
G |
Adar |
adenosine deaminase RNA specific |
treatment |
ISO |
DNA:SNP:enhancer: (rs4845384) (human) |
RGD |
PMID:24351124 |
RGD:125097515 |
NCBI chrNW_004936580:4,183,016...4,208,341
Ensembl chrNW_004936580:4,183,079...4,203,435
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:plasma (human) mRNA, protein:decreased expression:liver, serum (human) |
RGD |
PMID:21726101 PMID:25115832 PMID:27015844 |
RGD:25671432 RGD:25671433 RGD:5508214 |
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:missense mutations:cds:p.C112R, p.R158C (human) |
RGD |
PMID:20961200 |
RGD:14401585 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Birc3 |
baculoviral IAP repeat containing 3 |
ameliorates |
ISO |
|
RGD |
PMID:25902529 |
RGD:152998939 |
NCBI chrNW_004936551:5,544,047...5,556,550
Ensembl chrNW_004936551:5,544,065...5,556,555
|
|
G |
C2 |
complement C2 |
susceptibility |
ISO |
DNA:SNP:exon: p.Glu318Asp (human) |
RGD |
PMID:22610944 |
RGD:40886317 |
NCBI chrNW_004936727:1,602,400...1,615,974
Ensembl chrNW_004936727:1,602,398...1,616,060
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
severity |
ISO |
|
RGD |
PMID:17711627 |
RGD:14995339 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17657819 |
|
NCBI chrNW_004936560:42,561...45,748
Ensembl chrNW_004936560:42,537...45,807
|
|
G |
Cd274 |
CD274 molecule |
treatment |
ISO |
protein:increased expression:regulatory T cell |
RGD |
PMID:20460044 PMID:26266813 |
RGD:11344683 RGD:41412166 |
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
susceptibility |
ISO |
DNA:SNP:exon: p.Ser1254Asn (human) |
RGD |
PMID:22610944 |
RGD:40886317 |
NCBI chrNW_004936503:7,750,353...7,826,408
Ensembl chrNW_004936503:7,750,352...7,825,554
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
susceptibility |
ISO |
DNA:SNP: :-318C>T(human) |
RGD |
PMID:16489681 |
RGD:14398727 |
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
mRNA,protein:increased expression: peripheral blood mononuclear cell,serum, sinusoidal endothelium |
RGD |
PMID:18234638 PMID:30660173 |
RGD:27095888 RGD:27095951 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
ISO |
|
RGD |
PMID:26234401 |
RGD:32716425 |
NCBI chrNW_004936712:413,602...454,443
Ensembl chrNW_004936712:414,446...454,449
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA,protein:increased expression:peripheral blood mononuclear cell, liver: |
RGD |
PMID:18673437 PMID:21489307 |
RGD:38548921 RGD:38549358 |
NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
disease_progression treatment |
ISO |
|
RGD |
PMID:28007350 PMID:29279233 |
RGD:14975159 RGD:14975240 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:28465467 |
RGD:39939037 |
NCBI chrNW_004936843:658,058...672,662
Ensembl chrNW_004936843:657,979...672,700
|
|
G |
Ifng |
interferon gamma |
|
ISO |
protein:decreased expression:serum (human) |
RGD |
PMID:26684441 PMID:28465467 |
RGD:14974255 RGD:39939037 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:26062743 |
RGD:11097839 |
NCBI chrNW_004936519:6,166,060...6,180,652
Ensembl chrNW_004936519:6,175,261...6,180,396
|
|
G |
Il12b |
interleukin 12B |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs3212227) |
RGD |
PMID:25469587 |
RGD:11074616 |
NCBI chrNW_004936515:4,056,214...4,066,121
Ensembl chrNW_004936515:4,056,214...4,065,076
|
|
G |
Il18 |
interleukin 18 |
disease_progression |
ISO |
DNA:SNP:promoter:-607C>A(human) |
RGD |
PMID:27470888 |
RGD:14696663 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
severity |
ISO |
protein:increased expression:serum: |
RGD |
PMID:27180842 PMID:28381383 |
RGD:39457933 RGD:39938857 |
NCBI chrNW_004936713:1,020,969...1,035,012
Ensembl chrNW_004936713:1,021,044...1,035,039
|
|
G |
Il2 |
interleukin 2 |
susceptibility |
ISO |
DNA:polymorphism:promoter:-385T>G(human) |
RGD |
PMID:19105930 |
RGD:14747034 |
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
|
|
G |
Il21 |
interleukin 21 |
treatment susceptibility exacerbates |
ISO |
DNA:SNPs:introns: (rs2221903, rs907715) (human) DNA:SNP:intron: (rs2221903) (human) associated with non-alcoholic fatty liver disease protein:decreased expression:blood serum (human) protein:increased expression:blood serum (human) |
RGD |
PMID:23354321 PMID:25243706 PMID:26840345 PMID:28500636 PMID:29879024 PMID:30260401 PMID:31281514 PMID:32373234 More...
|
RGD:127285353 RGD:127285361 RGD:127285364 RGD:127285369 RGD:127285378 RGD:127285539 RGD:127285549 RGD:127285551 |
NCBI chrNW_004936662:1,689,879...1,696,883
Ensembl chrNW_004936662:1,689,879...1,696,883
|
|
G |
Il33 |
interleukin 33 |
severity treatment |
ISO |
|
RGD |
PMID:25714983 PMID:27180842 |
RGD:39457933 RGD:39938954 |
NCBI chrNW_004936539:763,755...791,461
Ensembl chrNW_004936539:623,248...791,470
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:24836184 |
RGD:40903002 |
NCBI chrNW_004936473:3,573,282...3,589,345
Ensembl chrNW_004936473:3,573,384...3,589,345
|
|
G |
Jak1 |
Janus kinase 1 |
disease_progression |
ISO |
DNA:SNPs: :rs4244165, rs17127024 (human) |
RGD |
PMID:22901011 |
RGD:19165132 |
NCBI chrNW_004936692:2,298,149...2,354,084
Ensembl chrNW_004936692:2,299,504...2,354,132
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:22459801 |
RGD:6892954 |
NCBI chrNW_004936659:785,059...793,775
Ensembl chrNW_004936659:782,340...793,688
|
|
G |
Krt18 |
keratin 18 |
disease_progression severity |
ISO |
protein:increased phosphorylation:liver (human) protein:increased degradation:serum (human) |
RGD |
PMID:20334631 PMID:28579343 |
RGD:18337487 RGD:18337494 |
NCBI chrNW_004936512:10,290,706...10,294,647
Ensembl chrNW_004936512:10,290,690...10,294,651
|
|
G |
Lepr |
leptin receptor |
|
ISO |
mRNA:altered expression:liver, peripheral blood mononuclear cell |
RGD |
PMID:17060687 |
RGD:21079470 |
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
G |
LOC101958908 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility disease_progression treatment |
ISO |
DNA:SNP: :rs3077(human) DNA:polymorphism::HLA-DPA1*04:01(human) CTD Direct Evidence: marker/mechanism mRNA:decreased expression:peripheral blood mononuclear cell: |
RGD CTD |
PMID:19349983 PMID:28275747 PMID:29300980 PMID:30267609 |
RGD:14694817 RGD:14694818 RGD:14694973 |
NCBI chrNW_004936476:25,743,512...25,750,809
Ensembl chrNW_004936476:25,743,456...25,750,907
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility treatment severity |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphisms, haplotypes:multiple (human) DNA:SNP:exon 6: (rs9277542) (human) DNA:polymorphisms:multiple (human) DNA:polymorphism: :(human) DNA:SNP:exon, 3' utr: (rs9277542) (human) DNA:polymorphism:exon, 3' utr: (rs9277535) (human) DNA:SNPs:multiple (human) DNA:SNP: :rs33054861(human) |
CTD RGD |
PMID:19349983 PMID:21274863 PMID:21310144 PMID:22737229 PMID:24520320 PMID:25109699 PMID:26449183 PMID:27051043 PMID:28267888 More...
|
RGD:11536957 RGD:14694816 RGD:14974232 RGD:150429660 RGD:150429794 RGD:150429799 RGD:150429802 RGD:150429807 RGD:150429808 |
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
|
|
G |
LOC101964975 |
interleukin-8 |
severity |
ISO |
mRNA, protein:increased expression:serum, peripheral blood mononuclear cell (human) associated with liver disease;mRNA, protein:increased expression:liver, blood serum (human) |
RGD |
PMID:23890815 PMID:26265888 |
RGD:11075958 RGD:150520196 |
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101976500 |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Mpl |
MPL proto-oncogene, thrombopoietin receptor |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:28871230 |
RGD:150340590 |
NCBI chrNW_004936474:24,744,673...24,757,189
Ensembl chrNW_004936474:24,744,673...24,757,085
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
disease_progression |
ISO |
DNA:enhancers: :(rs2233406, rs2233409) (human) |
RGD |
PMID:29093318 |
RGD:127285389 |
NCBI chrNW_004936494:9,537,793...9,541,187
Ensembl chrNW_004936494:9,537,008...9,541,612
|
|
G |
Pdcd1 |
programmed cell death 1 |
no_association disease_progression |
ISO |
mRNA:increased expression:liver parenchyma (human) protein:altered expression:serum: DNA:SNP:exon: DNA:SNPs::+7146 G>A,+7209 C>T(human) DNA:SNP:3' UTR:rs10204525(human) |
RGD |
PMID:20700634 PMID:22634051 PMID:25736598 PMID:28983583 PMID:30016557 |
RGD:36947881 RGD:40818231 RGD:40818233 RGD:40818262 RGD:40818415 |
NCBI chrNW_004936745:152,571...163,712
Ensembl chrNW_004936745:152,612...161,587
|
|
G |
Ppp1r15a |
protein phosphatase 1 regulatory subunit 15A |
|
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:26234401 |
RGD:32716425 |
NCBI chrNW_004936664:2,910,609...2,914,205
|
|
G |
Prdm1 |
PR/SET domain 1 |
disease_progression |
ISO |
|
RGD |
PMID:31100710 |
RGD:150530465 |
NCBI chrNW_004936564:2,594,362...2,690,680
Ensembl chrNW_004936564:2,667,660...2,690,683
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
ISO |
mRNA:decreased expression:monocyte (human) |
RGD |
PMID:30842274 |
RGD:41789632 |
NCBI chrNW_004936646:747,178...763,449
Ensembl chrNW_004936646:748,727...761,287
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
susceptibility |
ISO |
DNA:SNPs, haplotypes:multiple |
RGD |
PMID:25829184 |
RGD:25671420 |
NCBI chrNW_004936506:7,091,982...7,185,938
Ensembl chrNW_004936506:7,095,009...7,184,689
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
susceptibility |
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:30593207 |
RGD:39128221 |
NCBI chrNW_004936531:8,555,966...8,562,829
Ensembl chrNW_004936531:8,555,637...8,562,885
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
|
ISO |
mRNA:decreased expression:blood |
RGD |
PMID:21843574 |
RGD:6482248 |
NCBI chrNW_004936476:25,899,514...25,907,690
Ensembl chrNW_004936476:25,899,339...25,907,695
|
|
G |
Tert |
telomerase reverse transcriptase |
susceptibility |
ISO |
DNA:SNP, haplotype: :rs10069690,rs2242652(human) |
RGD |
PMID:29507683 |
RGD:14696786 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
no_association |
ISO |
DNA:SNPs:promoter:-509C>T (rs1800469) (human) DNA:SNPs, haplotypes: :869C>T (rs1800470), 11929C>T (rs1800472) (human) |
RGD |
PMID:28700046 |
RGD:14995436 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment disease_progression |
ISO |
protein:increased expression:serum: |
RGD |
PMID:25337250 PMID:25771704 PMID:28414577 |
RGD:15090812 RGD:15090826 RGD:15090828 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr3 |
toll like receptor 3 |
susceptibility |
ISO |
DNA:SNP, haplotype: :1234C>T (human) DNA:snp: :rs3775290(human) |
RGD |
PMID:23076446 PMID:26024592 |
RGD:21079416 RGD:21079425 |
NCBI chrNW_004936554:3,370,766...3,388,125
Ensembl chrNW_004936554:3,369,469...3,385,907
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:28414577 |
RGD:15090812 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
susceptibility |
ISO |
DNA:SNP,haplotypes: (rs148314165, rs200820567) (human) |
RGD |
PMID:28784141 |
RGD:151347613 |
NCBI chrNW_004936560:5,124,955...5,138,988
Ensembl chrNW_004936560:5,128,843...5,138,345
|
|
G |
Tnfsf13b |
TNF superfamily member 13b |
treatment |
ISO |
|
RGD |
PMID:30660173 |
RGD:27095888 |
NCBI chrNW_004936472:3,789,111...3,834,163
Ensembl chrNW_004936472:3,788,095...3,822,148
|
|
G |
Ube2l3 |
ubiquitin conjugating enzyme E2 L3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24162738 |
|
NCBI chrNW_004936619:2,070,836...2,137,314
Ensembl chrNW_004936619:2,070,731...2,137,369
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:20534899 |
RGD:151361169 |
NCBI chrNW_004936475:21,005,242...21,235,992
Ensembl chrNW_004936475:21,080,302...21,231,544
|
|